Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
JPM 2019
Marketing
Ingrezza-maker Neurocrine brings TD awareness to the tube
Neurocrine is looking to up awareness of movement disorder tardive dyskinesia with its brand-new TV spot.
Carly Helfand
Jan 25, 2019 12:20pm
Want to thrive, pharma? Forget 'me-too' drugs, CSL chief says
Jan 14, 2019 11:18am
Post-JPM buzz names Pfizer, Biogen as potential dealmakers
Jan 11, 2019 12:14pm
CEO told pharma to self-police pricing—then J&J hiked them
Jan 11, 2019 12:05pm
Clovis CEO to potential bidders: Step right up
Jan 11, 2019 11:33am
JPM wrapup: Must-reads from FDA to IPO to M&A
Jan 11, 2019 7:25am